Department of Molecular Medicine, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Research Center for Thalassemia and Hemoglobinopathy, Health Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Sci Rep. 2022 Mar 22;12(1):4856. doi: 10.1038/s41598-022-08986-4.
We studied the alpha-globin gene genotypes, hematologic values, and transfusion-dependence of patients with Hb H disease. Molecular characterization of alpha-thalassemia was performed. We identified 120 patients with Hb H disease. Of these patients, 35 (29.16%) had deletional form of Hb H disease, and 85 (70.83%) had different form of non-deletional Hb H disease. The most frequently observed Hb H genotypes were --/-α in 33 patients (27.5%), α α α in 25 cases (20.83%), αα/αα in 15 (12.5%), and αα/αα in 13 (10.83%) respectively. The probability of receiving at least one transfusion blood in deletional form was observed in 3 of 35 (8.57%) patients which just seen in 3 of 33 (9%) patients with --/-α genotype. This form was also observed in 8 of 85 (9.4%) patients in non-deletional Hb H diseases which five of them had Med deletion in compound with alpha globin point mutations. Nondeletional Hb H disease was more severe than deletional Hb H disease requiring more blood transfusions. We can recommend that Med deletion in compound with alpha-globin point mutations, polyA1 and constant spring in homozygous form needs to be taken into consideration when offering counseling to high-risk couples.
我们研究了血红蛋白 H 病患者的α-珠蛋白基因基因型、血液学值和输血依赖性。对α-地中海贫血进行了分子特征分析。我们共鉴定了 120 例血红蛋白 H 病患者。其中 35 例(29.16%)为缺失型血红蛋白 H 病,85 例(70.83%)为非缺失型血红蛋白 H 病。最常见的血红蛋白 H 基因型为 --/-α 在 33 例患者中(27.5%),ααα 在 25 例中(20.83%),αα/αα 在 15 例中(12.5%),αα/αα 在 13 例中(10.83%)。在 35 例缺失型患者中,有 3 例(8.57%)患者至少接受过一次输血,而在 33 例 --/-α 基因型患者中,仅有 3 例(9%)患者接受过输血。这种情况也发生在 85 例非缺失型血红蛋白 H 病患者中的 8 例,其中 5 例与α珠蛋白点突变复合的 Med 缺失。非缺失型血红蛋白 H 病比缺失型血红蛋白 H 病更严重,需要更多的输血。我们建议在为高危夫妇提供咨询时,应考虑 Med 缺失与α-珠蛋白点突变、多 A1 和恒春纯合子的复合。